Skip to main content

A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Completed · Phase 2 · NCT06046729

Conditions: Hidradenitis Suppurativa

At a glance

Research payments reported, 2025
$7.1M
U.S. investigators named
39
Sites paid
39
Planned or actual enrollment
352

About the trial

Sponsor
Eli Lilly and Company
Tested
Eltrekibart (drug), Placebo (drug)
Dates
Started 2023-10-23; completion 2026-08-17
Results posted
Not yet

This study aims to find the appropriately safe and effective dose and dosing frequency for eltrekibart in adults with moderate-to-severe hidradenitis suppurativa (HS) for further clinical development. The study will last approximately 62 weeks and may include up to 31 visits.

From ClinicalTrials.gov, last updated 2026-08-21. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Eli Lilly and Company reported $7.1M in research payments for this study in 2025 (40 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • American Oncology PArtners of Maryland PA $790,406
  • Revival Research Institute LLC $654,328
  • Skin Research of South Florida $592,872
  • Uh Cleveland Medical Center, OH $517,866
  • Direct Helpers Medical Center $425,311
  • Duke University $307,851
  • Alliance Clinical Research of Tampa $262,114
  • Medical University of South Carolina $257,727
  • Forward Clinical Trials Inc $245,621
  • Northwest Arkansas Clinical Trials $230,765
  • Best Skin Research LLC $226,921
  • 113 Efficient Services $224,259
  • Dermatology Specialists of Spokane $198,778
  • Allcutis Research LLC $193,009
  • Columbia Dermatology $175,151
  • University of Connecticut Health $168,445
  • Equity Medical LLC $160,032
  • Advanced Research Experts PLLC $154,681
  • Washington University $154,182
  • Djl Clinical Research PLLC $143,257
  • Academic Alliance in Dermatology $121,934
  • Jordan Valley Dermatology Center $115,148
  • Medical College of Wisconsin Inc $98,671
  • Dermatology Institute and Skin Care $81,027
  • Beth Israel Deaconess Medical Center, MA $73,285
  • Skin Specialists PC $68,596
  • International Clinical Research $68,195
  • Dawes Fretzin Clinical Research Group LLC $58,791
  • Modern Research Associates PLLC $58,717
  • Southwest Skin Specialists LLC $57,341
  • University of Miami $50,702
  • Arkansas Research Trials LLC $50,179
  • Dermatology Research Associates Inc $44,920
  • Eximia Research Acquisition Ho $44,882
  • North Texas Center for Clinical Research LLC $8,673
  • Advanced Medical Research Inc $7,758
  • Gsi Clinical Research LLC $4,000
  • Northshore University Healthsystem - Evanston Hospital, IL $3,754
  • Skin Sciences, PLLC $2,500

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.